Product Supply Layout of China's Regenerative Medicine Industry
From the point of view of product categorization, regenerative medicine can be divided into three major segments: regenerative materials, stem cell repair, and regenerative organs. Regenerative materials can be used for bone repair, oral repair, medical beauty, etc.; stem cell repair, based on stem cell technology, repair the original non-renewable tissues and organs; regenerative organs, based on stem cells, biological 3D printing and other technologies, the development of man-made tissues and organs, including artificial blood vessels, artificial kidneys, artificial pancreas and so on. At present, China's regenerative medicine enterprises focus on regenerative materials and stem cell repair field, and regenerative organs are regarded as artificial organs of the "tip of the pyramid", the layout of regenerative organs of the enterprise is less.
Regenerative medicine industry representative enterprises product production and sales comparison
Currently, China's regenerative medicine industry, several major listed companies are through the research and development, production and sales of regenerative medical device products to achieve income, and most of them are implantable medical devices, but in the products applicable to the disease there is a difference. For example, the active biological bone products of Zhenghai Biotechnology are used in orthopedic diseases, and the artificial biological heart valve products of Bairen Medical are used in heart diseases. From the point of view of the production and sales of each enterprise's products, in 2022, affected by the macro-economy and the medical industry collection, Zheng Hai Biological, Maipu medical, Bai Ren medical products production and sales rate are lower than 100%, resulting in a certain amount of inventory; Guanhao biological production and sales rate of 210.02%, in fact, the sales volume compared with the previous year is down, mainly due to the existence of a large amount of inventory in the previous year, the company 2022 to reduce the production of the product.
Regenerative medicine industry import and export trade analysis
--Import trade is a growing trend
China's regenerative medicine industry is in the early stages of development, product competitiveness is not strong, high-end products still need to be imported from the United States, Germany, Germany and other countries. products still need to be imported from the United States, Germany, the Netherlands and other countries. From the import trade situation, from 2017 to 2022, China's regenerative medicine industry import trade overall growth trend, the total import volume from 349.55 tons in 2017 to 460.56 tons in 2022, 2020 by the new crown epidemic, the total volume of imports has declined. The total amount of imports is consistent with the change in import volume, in 2022, China's regenerative medicine industry imports totaled 5.540 billion yuan. in January-March 2023, China's regenerative medicine industry imported a total of 120.20 tons, the total amount of imports of 1.461 billion yuan.
Note: Import and export trade data queried product tariff number: 90213900 (including artificial heart valves, other artificial human body parts and other medical device products), the same below.
-- Export trade is more stable
Export, China's regenerative medicine industry export trade business is mainly to India, Egypt, Pakistan and other developing countries.2017-2022, China's regenerative medicine industry export trade changes are relatively stable, with the export volume fluctuating around 250-300 tons.In 2022, the total export volume of China's regenerative medicine industry was 290.74 tons, and the total export volume was 292 million yuan.From January to March 2023, the total export volume was 75.12 tons, and the total export volume was 87 million yuan.
Chinese regenerative medicine industry export trade business is mainly to developing countries such as India, Egypt and Pakistan.
--The average price of product import is much higher than the average price of export
Based on the above analysis, it can be found that there is a big difference between the total import and export trade of China's regenerative medicine industry. From the perspective of average price of products, the average import price of regenerative medicine products in China in 2018-2023 is above 10,000 yuan/kg, much higher than the average export price of about one thousand dollars. For example, in 2022, China's regenerative medicine industry product import average price is 12028 yuan/kg, export average price is 1004 yuan/kg, import average price is more than ten times of the export average price. Mainly due to China's main to the United States, Germany and other developed countries in science and technology imports of high-end regenerative medical devices, product value is higher; and exports are mainly for developing countries to export low-end products with low product value.
More research and analysis of this industry see the Prospect Industry Research Institute "China's biomedical industry development outlook and investment strategy planning analysis report".